Vimarsana
Biggest News Aggregation in the World

Page 17 - Poster Presentation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Presentation Today - Breaking & Trending Today

Studies in HIV Prevention, Athletic Injury Recovery, and Diabetes Receive AMCP Foundation Best Poster Awards - Vimarsana News

Studies in HIV Prevention, Athletic Injury Recovery, and Diabetes Receive AMCP Foundation Best Poster Awards

ALEXANDRIA, Va., Nov. 17, 2022 /PRNewswire/ -- Congratulations to Kathryn DeStefano, Matthew Dickson, and Weston Schmutz, the recipients of AMCP F...

Net Health's Research Team to Present Data on Key Findings at ACRM Conference - Vimarsana News

Net Health's Research Team to Present Data on Key Findings at ACRM Conference

/PRNewswire/ -- Highlighting the company's industry leadership, Net Health Research and Clinical Outcomes was selected to give three presentations at the 99th...

G1 Therapeutics Provides Third Quarter 2022 Financial - Vimarsana News

G1 Therapeutics Provides Third Quarter 2022 Financial

- Achieved $23.6 million in Total Revenue in the Third Quarter of 2022 Including $8.3 million in Net Revenue from Sales of COSELA® (trilaciclib) - -...

Leap Therapeutics to Present Updated Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab and Preclinical Data in Colorectal Cancer Models at the SITC Annual Meeting - Vimarsana News

Leap Therapeutics to Present Updated Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab and Preclinical Data in Colorectal Cancer Models at the SITC Annual Meeting

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

New Real-World Data Presented at OPTIONS XI Show Cell-Based and MF59®-Adjuvanted Influenza Vaccines Can Reduce the Burden of Seasonal Influenza on Hospitals and Health Systems - Vimarsana News

New Real-World Data Presented at OPTIONS XI Show Cell-Based and MF59®-Adjuvanted Influenza Vaccines Can Reduce the Burden of Seasonal Influenza on Hospitals and Health Systems

SUMMIT, N.J., Sept. 26, 2022 /PRNewswire/ -- CSL Seqirus, a business of CSL Limited (ASX:CSL), today announced new data from four real-world studi...